Zi Wang

534 total citations
44 papers, 345 citations indexed

About

Zi Wang is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Pathology and Forensic Medicine. According to data from OpenAlex, Zi Wang has authored 44 papers receiving a total of 345 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Cardiology and Cardiovascular Medicine, 8 papers in Surgery and 8 papers in Pathology and Forensic Medicine. Recurrent topics in Zi Wang's work include Atrial Fibrillation Management and Outcomes (5 papers), Renal Diseases and Glomerulopathies (5 papers) and Chronic Lymphocytic Leukemia Research (3 papers). Zi Wang is often cited by papers focused on Atrial Fibrillation Management and Outcomes (5 papers), Renal Diseases and Glomerulopathies (5 papers) and Chronic Lymphocytic Leukemia Research (3 papers). Zi Wang collaborates with scholars based in China, United States and Canada. Zi Wang's co-authors include Meng Jiang, Jun Pu, Xuan Su, Xiaoye Li, Lingling Wang, Ben He, Jicheng Lv, Qiuyi Ji, Hong Zhang and Shijia Liu and has published in prestigious journals such as Blood, Scientific Reports and Small.

In The Last Decade

Zi Wang

34 papers receiving 342 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zi Wang China 10 85 82 68 51 50 44 345
Brittny Major United States 8 33 0.4× 89 1.1× 37 0.5× 23 0.5× 22 0.4× 14 335
Ioannis Petrakis Greece 13 126 1.5× 61 0.7× 87 1.3× 13 0.3× 231 4.6× 43 506
Chun‐Lan Chang United States 11 67 0.8× 70 0.9× 53 0.8× 12 0.2× 23 0.5× 27 400
Henk J Adriaansen Netherlands 13 133 1.6× 177 2.2× 48 0.7× 13 0.3× 26 0.5× 29 665
Pilar Auñón Spain 12 51 0.6× 206 2.5× 48 0.7× 17 0.3× 54 1.1× 40 546
Jin Lü China 12 43 0.5× 61 0.7× 104 1.5× 16 0.3× 30 0.6× 36 380
Daisuke Kanda Japan 12 69 0.8× 80 1.0× 101 1.5× 22 0.4× 10 0.2× 55 371
Diana Chin Italy 13 140 1.6× 213 2.6× 136 2.0× 24 0.5× 26 0.5× 31 658
Paula F. Ypma Netherlands 15 92 1.1× 162 2.0× 63 0.9× 52 1.0× 5 0.1× 57 770
Ralph Quimbo United States 12 48 0.6× 31 0.4× 156 2.3× 13 0.3× 19 0.4× 30 564

Countries citing papers authored by Zi Wang

Since Specialization
Citations

This map shows the geographic impact of Zi Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zi Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zi Wang more than expected).

Fields of papers citing papers by Zi Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zi Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zi Wang. The network helps show where Zi Wang may publish in the future.

Co-authorship network of co-authors of Zi Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Zi Wang. A scholar is included among the top collaborators of Zi Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zi Wang. Zi Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Wang, Zi, et al.. (2026). Bleeding risk of rivaroxaban and edoxaban with and without amiodarone in atrial fibrillation patients: a prospective cohort study. European Journal of Clinical Pharmacology. 82(3). 75–75.
4.
Wei, Chong, Wei Zhang, Daobin Zhou, et al.. (2025). Golidocitinib combined with CHOP in newly-diagnosed peripheral T-cell lymphoma: Preliminary Results from A phase 1/2 clinical trial. Blood. 146(Supplement 1). 6322–6322.
5.
6.
Dolinger, Michael T., Brad D. Constant, Zi Wang, et al.. (2025). Ustekinumab is safe and effective in pediatric patients with Crohn's disease. Journal of Pediatric Gastroenterology and Nutrition. 80(4). 653–663.
7.
8.
Qiao, Yongxia, Zi Wang, Qi-Zhen Wu, et al.. (2025). Somatic symptom disorder in patients with myocardial bridge: cross-sectional study in China. BJPsych Open. 11(2). e67–e67.
9.
Wang, Zi, et al.. (2024). Clinical efficacy of clopidogrel and ticagrelor in patients undergoing off-pump coronary artery bypass grafting: a retrospective cohort study. International Journal of Surgery. 110(6). 3450–3460. 1 indexed citations
10.
Chen, Hongyun, Wei Wang, Chong Wei, et al.. (2024). Lymphoma relapse 1 year or later after immunochemotherapy in DLBCL patients: clinical features and outcome. Clinical and Experimental Medicine. 24(1). 48–48. 2 indexed citations
11.
Wang, Zi, Shu‐Feng Zhou, Sufang Shi, et al.. (2024). Clinical Implications of C2 Lesion in IgA Nephropathy: A Cohort Study. American Journal of Nephrology. 55(5). 529–538. 1 indexed citations
12.
Wei, Chong, Shuqing Wang, Yan Zhang, et al.. (2023). The intrinsic defects of T cells impact the efficacy of CAR-T therapy in patients with diffuse large B-cell lymphoma. Blood Cancer Journal. 13(1). 186–186. 7 indexed citations
13.
Lassó, András, Jing Huang, Zi Wang, et al.. (2022). Visualization and Quantification of the Unrepaired Complete Atrioventricular Canal Valve Using Open-Source Software. Journal of the American Society of Echocardiography. 35(9). 985–996.e11. 4 indexed citations
14.
Zhou, Yingjie, Zi Wang, Mingxue Zhou, et al.. (2022). Efficacy and safety of Tonifying Qi and activating blood Chinese herbal prescriptions for myocardial infarction: Study protocol for a multi-centered RCT. Medicine. 101(47). e31680–e31680. 1 indexed citations
15.
Li, Xiaoye, et al.. (2022). Evaluation of pharmacist-led telemedicine medication management for hypertension established patients during COVID-19 pandemic: A pilot study. Frontiers in Public Health. 10. 1091484–1091484. 9 indexed citations
16.
Yao, Yao, Xiaoye Li, Zi Wang, et al.. (2022). Interaction of Lipids, Mean Platelet Volume, and the Severity of Coronary Artery Disease Among Chinese Adults: A Mediation Analysis. Frontiers in Cardiovascular Medicine. 9. 753171–753171. 10 indexed citations
17.
Wang, Zi, et al.. (2020). Genetic Polymorphisms and Perioperative Bleeding in Off-Pump Coronary Artery Bypass Grafting Surgery. The Annals of Thoracic Surgery. 112(1). 116–123. 2 indexed citations
18.
Zhang, Yuemiao, Ling Guo, Zi Wang, et al.. (2020). External Validation of International Risk-Prediction Models of IgA Nephropathy in an Asian-Caucasian Cohort. Kidney International Reports. 5(10). 1753–1763. 27 indexed citations
19.
Jiang, Meng, Zi Wang, Xuan Su, et al.. (2018). The Significance of Interstitial Fibrosis on Left Ventricular Function in Hypertensive versus Hypertrophic Cardiomyopathy. Scientific Reports. 8(1). 9995–9995. 5 indexed citations
20.
Wang, Zi, Lingling Wang, Xuan Su, et al.. (2017). Rational transplant timing and dose of mesenchymal stromal cells in patients with acute myocardial infarction: a meta-analysis of randomized controlled trials. Stem Cell Research & Therapy. 8(1). 21–21. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Brittny Major Breakdown of academic impact, for papers by Ioannis Petrakis Breakdown of academic impact, for papers by Chun‐Lan Chang Breakdown of academic impact, for papers by Henk J Adriaansen Breakdown of academic impact, for papers by Pilar Auñón Breakdown of academic impact, for papers by Jin Lü Breakdown of academic impact, for papers by Daisuke Kanda Breakdown of academic impact, for papers by Diana Chin Breakdown of academic impact, for papers by Paula F. Ypma Breakdown of academic impact, for papers by Ralph Quimbo
Rankless by CCL
2026